Further investigation of the NOTCH3 −exon 16 transcript as an independent prognostic biomarker was not pursued given the low sample size, yet the results suggests that expression of the NOTCH3 −exon 16 transcript has prognostic potential within GCB DLBCL. The gene discussed is NOTCH3; the disease is diffuse large B-cell lymphoma.